Deutsche Bank
http://www.db.com/
Deutsche Bank is a leading global investment bank with a strong and profitable private clients franchise.
The company operates through three divisions: Corporate and Investment Bank (CIB), Private Clients and Asset Management (PCAM) and Corporate Investments (CI) . The CIB division engages in the origination, sale, financing, structuring, and trading of fixed income, equity, equity-linked, convertible bond, foreign exchange, and commodities products. The PCAM segment provides portfolio/fund management products, including active fund management, passive/quantitative fund management, alternative investments, and discretionary portfolio management solutions in Germany and other continental European countries.-
Deutsche Bank Cuts BioMarin Pharma (BMRN) to Hold Following Q4 Earnings
-
Daily State of the Markets 12/02: Unconventional Measures?
-
Deutsche Bank Initiates Coverage on BioMarin Pharmaceuticals (BMRN) with a Buy; Two Shots on Goal in 2011 for Additional Value
-
Notable Analyst Rating Changes 1/7: BAC, SHLD, THC, IT, ZUMZ, CITP Upgraded; RAI, AA, RAD, WEN, BEXP Downgraded
